|
1
|
Riggs BL and Melton LJ III: The worldwide
problem of osteoporosis: Insights afforded by epidemiology. Bone.
17 (17 Suppl):505S–511S. 1995.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lane NE: Epidemiology, etiology, and
diagnosis of osteoporosis. Am J Obstet Gynecol. 194 (2
Suppl):S3–S11. 2006.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Varacallo MA and Fox EJ: Osteoporosis and
its complications. Med Clin North Am. 98:817–831. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
World Health Organization (WHO): WHO
Scientific Group on the Assessment of Osteoporosis at Primary
Health Care Level. Summary Meeting Report, Brussels, Belgium, 5-7
May 2004. WHO Press, Geneva, 2007.
|
|
5
|
Kling JM, Clarke BL and Sandhu NP:
Osteoporosis prevention, screening, and treatment: A review. J
Womens Health (Larchmt). 23:563–572. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wells GA, Cranney A, Peterson J, Boucher
M, Shea B, Robinson V, Coyle D and Tugwell P: Alendronate for the
primary and secondary prevention of osteoporotic fractures in
postmenopausal women. Cochrane Database Syst Rev.
23(CD001155)2008.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Nelson HD, Haney EM, Dana T, Bougatsos C
and Chou R: Screening for osteoporosis: An update for the U.S.
Preventive services task force. Ann Intern Med. 153:99–111.
2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Pendrys DG and Silverman SL: Osteonecrosis
of the jaws and bisphosphonates. Curr Osteoporos Rep. 6:31–38.
2008.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Andreopoulou P and Bockman RS: Management
of postmenopausal osteoporosis. Annu Rev Med. 66:329–342.
2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ko CH, Siu WS, Lau CP, Lau CBS, Fung KP
and Leung PC: Osteoprotective effects of fructus ligustri lucidi
aqueous extract in aged ovariectomized rats. Chin Med.
5(39)2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li G, Zhang XA, Zhang JF, Chan CY, Yew
DTW, He ML, Lin MCM, Leung PC and Kung HF: Ethanol extract of
fructus ligustri lucidi promotes osteogenesis of mesenchymal stem
cells. Phyther Res. 24:571–576. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Zhang JF, Li G, Chan CY, Meng CL, Lin MCM,
Chen YC, He ML, Leung PC and Kung HF: Flavonoids of herba epimedii
regulate osteogenesis of human mesenchymal stem cells through BMP
and Wnt/β-catenin signaling pathway. Mol Cell Endocrinol.
314:70–74. 2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hu J, Webster D, Cao J and Shao A: The
safety of green tea and green tea extract consumption in
adults-results of a systematic review. Regul Toxicol Pharmacol.
95:412–433. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Khan N and Mukhtar H: Tea and health:
Studies in humans. Curr Pharm Des. 19:6141–6147. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hegarty VM, May HM and Khaw KT: Tea
drinking and bone mineral density in older women. Am J Clin Nutr.
71:1003–1007. 2000.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ko CH, Lau KM, Choy WY and Leung PC:
Effects of tea catechins, epigallocatechin, gallocatechin, and
gallocatechin gallate, on bone metabolism. J Agric Food Chem.
57:7293–7297. 2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kashiwa K, Kotobuki N, Tadokoro M,
Matsumura K, Hyon SH, Yoshiya S and Ohgushi H: Effects of
epigallocatechin gallate on osteogenic capability of human
mesenchymal stem cells after suspension in phosphate-buffered
saline. Tissue Eng Part A. 16:91–100. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ko CH, Siu WS, Wong HL, Shum WT, Fung KP,
Lau CBS and Leung PC: Pro-bone and antifat effects of green tea and
its polyphenol, epigallocatechin, in rat mesenchymal stem cells in
vitro. J Agric Food Chem. 59:9870–9876. 2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Shen CL, Wang P, Guerrieri J, Yeh JK and
Wang JS: Protective effect of green tea polyphenols on bone loss in
middle-aged female rats. Osteoporos Int. 19:979–990.
2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Shen CL, Yeh JK, Samathanam C, Cao JJ,
Stoecker BJ, Dagda RY, Chyu MC and Wang JS: Protective actions of
green tea polyphenols and alfacalcidol on bone microstructure in
female rats with chronic inflammation. J Nutr Biochem. 22:673–680.
2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Shen CL, Smith BJ, Li J, Cao JJ, Song X,
Newhardt MF, Corry KA, Tomison MD, Tang L, Wang JS and Chyu MC:
Effect of long-term green tea polyphenol supplementation on bone
architecture, turnover, and mechanical properties in middle-aged
ovariectomized rats. Calcif Tissue Int. 104:285–300.
2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Dostal AM, Arikawa A, Espejo L and Kurzer
MS: Long-term supplementation of green tea extract does not modify
adiposity or bone mineral density in a randomized trial of
overweight and obese postmenopausal women. J Nutr. 146:256–264.
2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ko CH, Siu WS, Wong HL, Gao S, Shum WT,
Lau CP, Cheng SW, Tam JCW, Hung LK, Fung KP, et al: In vivo study
on the pharmacological interactions between a chinese herbal
formula ELP and antiresorptive drugs to counteract osteoporosis.
Evid Based Complement Altern Med. 2012(203732)2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wu X, Xie CQ, Zhu QQ, Wang MY, Sun B,
Huang YP, Shen C, An MF, Zhao YL, Wang XJ and Sheng J: Green tea
(Camellia sinensis) aqueous extract alleviates
postmenopausal osteoporosis in ovariectomized rats and prevents
RANKL-induced osteoclastogenesis in vitro. Food Nutr Res.
8(62)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Nair AB and Jacob S: A simple practice
guide for dose conversion between animals and human. J Basic Clin
Pharm. 7:27–31. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Halleen JM, Tiitinen SL, Ylipahkala H,
Fagerlund KM and Väänänen HK: Tartrate-resistant acid phosphatase
5b (TRACP 5b) as a marker of bone resorption. Clin Lab. 52:499–509.
2006.PubMed/NCBI
|
|
27
|
Rey JR, Cervino EV, Rentero ML, Crespo EC,
Alvaro AO and Casillas M: Raloxifene: Mechanism of action, effects
on bone tissue, and applicability in clinical traumatology
practice. Open Orthop J. 3:14–21. 2009.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Pavone V, Testa G, Giardina SMC, Vescio A,
Restivo DA and Sessa G: Pharmacological therapy of osteoporosis: A
systematic current review of literature. Front Pharmacol.
8(830)2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Dulloo AG, Seydoux J, Girardier L, Chantre
P and Vandermander J: Green tea and thermogenesis: Interactions
between catechin-polyphenols, caffeine and sympathetic activity.
Int J Obes Relat Metab Disord. 24:252–258. 2000.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chacko SM, Thambi PT, Kuttan R and
Nishigaki I: Beneficial effects of green tea: A literature review.
Chin Med. 5(13)2010.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Smith A: Effects of caffeine on human
behavior. Food Chem Toxicol. 40:1243–1255. 2002.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Cheng TO: Green tea may inhibit warfarin.
Int J Cardiol. 115(236)2007.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Izzo AA: Interactions between herbs and
conventional drugs: Overview of the clinical data. Med Princ Pract.
21:404–428. 2012.PubMed/NCBI View Article : Google Scholar
|
